Moderna’s coronavirus vaccine is safe and effective in children aged 12-17, the company announced on Tuesday morning.
The company’s study, which included 3,700 participants in the age range, found that no patient who received two doses of the vaccine got the coronavirus. Additionally, it showed an efficacy of 93% after one dose.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.